<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05126108</url>
  </required_header>
  <id_info>
    <org_study_id>APHP210278</org_study_id>
    <nct_id>NCT05126108</nct_id>
  </id_info>
  <brief_title>Decurarisation Kinetics of Rocuronium in Cervical Surgery</brief_title>
  <acronym>CIDEROC</acronym>
  <official_title>Evaluation of the Decurarisation Kinetics of Rocuronium in Cervical Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recurrent nerve monitoring for thyroid and parathyroid surgery contraindicates the&#xD;
      pharmacologically active presence of muscle relaxant agents at the time of dissection. A&#xD;
      recent formalized expert guideline (RFE 2018) from the French Society of Anesthesia and&#xD;
      Resuscitation, SFAR recommends administering a curare to facilitate tracheal intubation and&#xD;
      limit laryngeal trauma . This study aims to determine if the level of neuromuscular recovery&#xD;
      is consistent with monitoring the recurrent nerve after the use of rocuronium for intubation.&#xD;
&#xD;
      Primary endpoint: Achievement of quality intraoperative laryngeal recurrent nerve monitoring.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The monitoring of the recurrent nerves, innervating the vocal cords, in thyroid and&#xD;
      parathyroid surgery has developed in recent years because of its interest as a parameter to&#xD;
      reduce the risk of recurrent paralysis.&#xD;
&#xD;
      Monitoring of the recurrent nerves requires contraction of the laryngeal muscle and therefore&#xD;
      contraindicates the pharmacologically active presence of muscle relaxants at the time of&#xD;
      dissection. Thus, intubation was performed either without curare or with a depolarizing&#xD;
      curare (Succinylcholine) whose short duration of action allowed optimal intubation conditions&#xD;
      without intraoperative residual effect.&#xD;
&#xD;
      This practice is being questioned due to :&#xD;
&#xD;
      (i) a recent formalized expert referential (RFE) of the French Society of Anesthesia and&#xD;
      Resuscitation, SFAR, which recommends administering a curare to facilitate intubation of the&#xD;
      trachea and limit laryngeal trauma (grade 1 +) and (ii) a restriction of the indications of&#xD;
      succinylcholine by the French National Agency for the Safety of Medicines and Health&#xD;
      Products, ANSM, as an adjuvant of general anaesthesia (induction in rapid sequence and&#xD;
      electroconvulsive therapy).&#xD;
&#xD;
      In summary, thyroid surgery requires curarisation for intubation and sufficient&#xD;
      intraoperative decurarisation to allow monitoring of the recurrent nerves. We hypothesize&#xD;
      that the time between intubation and the actual start of recurrent monitoring is consistent&#xD;
      with the time to recovery of laryngeal adductor neuromuscular block after injection of&#xD;
      rocuronium at a dosage of 0.5 mg/kg.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality intraoperative monitoring of the recurrent laryngeal nerve</measure>
    <time_frame>During surgery</time_frame>
    <description>To assess the decurarization kinetics of rocuronium: to determine if the level of neuromuscular recovery is compatible with monitoring of the recurrent nerve after the use of rocuronium for intubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Copenhagen score</measure>
    <time_frame>During surgery</time_frame>
    <description>Evaluate the intubation conditions 3 minutes after the injection of rocuronium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial pressions</measure>
    <time_frame>During surgery</time_frame>
    <description>Evaluate the hemodynamic variations induced by anesthetic induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac frequency</measure>
    <time_frame>During surgery</time_frame>
    <description>Evaluate the hemodynamic variations induced by anesthetic induction</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Non-morbidly Obese Patients (BMI&lt;35)</condition>
  <condition>Equiring General Anesthesia With Intubation With a Nerve Integrity Monitor (NIM) Tube</condition>
  <condition>Thyroid and Parathyroid Surgery</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thyroid and parathyroid surgery</intervention_name>
    <description>Thyroid and parathyroid surgery</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recurrent nerves monitoring</intervention_name>
    <description>Recurrent nerves monitoring</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Major, non-morbidly obese patients (BMI&lt;35) requiring general anesthesia with intubation&#xD;
        with a Nerve Integrity Monitor (NIM) tube for thyroid and parathyroid surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult subjects requiring general anesthesia for cephalic surgery (thyroid and&#xD;
             parathyroid) with an NIM-type intubation tube.&#xD;
&#xD;
          -  Subject informed of the study and not having opposed it&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to any of the products used&#xD;
&#xD;
          -  Morbidly obese subjects (BMI&gt; 35)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Predictive criteria for difficult intubation in pre-anesthetic consultation&#xD;
&#xD;
          -  Subjects under tutorship or curatorship&#xD;
&#xD;
          -  Subjects not affiliated to social security&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Christophe BAILLARD</last_name>
    <phone>00 33 1 58 41 14 87</phone>
    <email>christophe.baillard@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie BENHAMMANI-GODARD</last_name>
    <phone>00 33 1 58 41 11 90</phone>
    <email>marie.godard@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Surgical anesthesia service - Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <state>IDF</state>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Christophe BAILLARD</last_name>
      <phone>00 33 1 58 41 14 87</phone>
      <email>christophe.baillard@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe BAILLARD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 8, 2021</study_first_submitted>
  <study_first_submitted_qc>November 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thyroid and parathyroid surgery</keyword>
  <keyword>Recurrent nerves monitoring</keyword>
  <keyword>Rocuronium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parathyroid Hormone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

